PRATHIBA M. SINGH
Dharmendra Kumar Aggarwal – Appellant
Versus
Govt Of NCT Of Delhi – Respondent
JUDGMENT
Prathiba M. Singh, J. - This hearing has been done through video conferencing.
CM APPL. 15878/2021(for exemption)
2. Allowed, subject to all just exceptions. Application is disposed of.
CM APPLs. 15879-80/2021(exemption from filing court fee and attested affidavits)
3. These are applications seeking exemption from filing court fee and duly notarized affidavits. Binding the deponent of the affidavit to the contents of the application, the exemption is granted. Insofar as the court fee is concerned, the same be deposited within one week. Applications are disposed of. Registry to submit a report in case the court fees is not filed after a month.
W.P.(C) 5173/2021
4. The present petition is concerned with the supply and availability of the drug Tocilizumab 400 MG for COVID-19 patients who are prescribed the same.
5. Vide order dated 6th May 2021, this court had recorded that Tocilizumab 400 MG had been made available for the Petitioner's brother and was administered to the patient. Mr. Tandon, ld. Counsel for the Petitioner further submitted, as recorded in order dated 10th May 2021, that the patient's medical condition is better.
6. On 6th May 2021, this court had also impleaded an
The central legal point established in the judgment is the uncertainty in the further imports of Tocilizumab to India and the efforts made by Roche India to import and supply the drug, as well as the....
The court asserted the need for government accountability in drug distribution and ordered comprehensive reporting on the supply capabilities of Tocilizumab amid urgent demand due to COVID-19.
The main legal point established is the court's intervention to address the shortage of Tocilizumab 400 MG for COVID-19 patients in India, emphasizing the need for the manufacturer to meet the demand....
Court mandates government engagement to enhance drug supply for COVID-19 patients, emphasizing transparency and efficiency in distribution amidst a health crisis.
Court emphasizes urgency and coordinated efforts to ensure availability of critical medicine for COVID-19 patients while addressing broader supply chain issues.
Urgent assessment and supply of essential drugs in public health emergencies.
During a national emergency, the government can exercise powers under the Patents Act to ensure the availability of essential drugs, emphasizing public health needs amid a pandemic.
The main legal point established is the need for immediate availability of essential drugs, such as Tocilizumab, for critically ill COVID-19 patients and the provisions of the Patents Act allowing fo....
Interim order modified - It is settled law Court always has power to vary or modify any interim order for good and cogent reason. Respondent-Applicant had made a voluntary statement that in meantime;....
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.